Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatment of Actinic Keratoses in Organ Transplant Recipients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effectiveness and safety of multiple applications of imiquimod 5% cream for actinic keratoses in organ transplant recipients is com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Imiquimod 5% cream (Imiquimod)

Snippet

Sponsor: MEDA Pharma GmbH & Co. KG | Conditions: Actinic Keratosis | Phase 2 | Status: COMPLETED